The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
Triple negative breast (TNBC) cancer constitutes a heterogeneous group of disease with histologic and molecular differences. Complete pathologic response to neoadjuvant chemotherapy (NACT) in TNBC is associated with improved outcomes. Efforts have been made in identifying drug combinations that will...
Saved in:
Main Authors: | Aurelio Bartolome Castrellon (Author), Ihor Pidhorecky (Author), Vicente Valero (Author), Luis Estuardo Raez (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017) -
The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016) -
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024) -
Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy
by: Xing Wang, et al.
Published: (2024) -
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
by: Hao Tian, et al.
Published: (2021)